Location History:
- Ibaraki, JP (2005 - 2007)
- Tsukuba, JP (2003 - 2012)
- Tokyo, JP (2008 - 2019)
Company Filing History:
14 out of 417 
1 out of 329 Years Active: 2003-2019
Title: The Innovative Contributions of Keizo Sugasawa
Introduction
Keizo Sugasawa is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Sugasawa has made remarkable advancements in the development of compounds that address various medical conditions.
Latest Patents
One of Sugasawa's latest patents involves a piperazine derivative, which serves as an MCreceptor agonist. This compound has been identified as having potential applications in preventing or treating bladder and urinary tract diseases, including underactive bladder and voiding dysfunctions associated with benign prostatic hyperplasia. Another notable patent is for a 2-acylaminothiazole derivative, which has shown excellent effects in proliferating human c-mpl-Ba/F3 cells and increasing platelet counts, making it useful in treating thrombocytopenia.
Career Highlights
Throughout his career, Sugasawa has worked with leading pharmaceutical companies, including Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions.
Collaborations
Sugasawa has collaborated with notable colleagues such as Fukushi Hirayama and Yuji Koga. These partnerships have fostered innovation and have contributed to the successful development of his patented compounds.
Conclusion